États-Unis · Bourse & Finance · Quartz

Roche struck a cancer drug licensing deal with China's Hansoh that could exceed $15 billion

Publié par Quartz · États-Unis il y a 1 h

Hansoh will receive $400 million upfront and keep rights to the programs in mainland China, Hong Kong, Macau and Taiwan

Lire l'article complet sur Quartz Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (qz.com)

À lire aussi

Women may be at greater risk of AI job losses. Telephone switch operators and PCs show why

Business Insider

AI could eat Big Law's billable hours. Cooley's boss says bring it on.

Trump Defends Russia Sanctions Waiver as Rift With Ukraine Deepens

How Boston Dynamics is turning robots into a real business

Strategy Buys $22M in Bitcoin, Buys Back $193M of STRC

Apple updates guidelines to ban nudify apps masquerading as regular apps to pass review